Metraipolis › archive › dc_848424ff229b

Asymptomatic Pembrolizumab-Associated Hypertriglyceridemia — Europe PMC PMID:42403766

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42403766
DOI
10.7759/cureus.110286
License (as archived)
solo-consultazione
Archived
2026-10-31T18:23:25.997Z
SHA-256 of the archived text
005d056c727dc42c19dbf35f29158ac3e258bfd57c5a737769e4ae7dbcdb737b
Stable URL of this page
https://metraipolis.com/documento/dc_848424ff229b

How to cite

Asymptomatic Pembrolizumab-Associated Hypertriglyceridemia — Europe PMC PMID:42403766 — Europe PMC (en), https://europepmc.org/article/MED/42403766 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_848424ff229b (Metraipolis archive dc_848424ff229b, sha256 005d056c727dc42c19dbf35f29158ac3e258bfd57c5a737769e4ae7dbcdb737b)
BibTeX
@misc{dc848424ff229b,
  title = {Asymptomatic Pembrolizumab-Associated Hypertriglyceridemia — Europe PMC PMID:42403766},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42403766},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_848424ff229b; sha256 005d056c727dc42c19dbf35f29158ac3e258bfd57c5a737769e4ae7dbcdb737b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42403766. Agents can read the archived copy with the MCP tool read_document.